StockData
QuidelOrtho Corp logo

QuidelOrtho Corp (QDEL) stock

QDELNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends January 1
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3063% below fair value
$9.87−0.34 (-3.33%)

Close on Nov 17, 2026Market cap $676.84MP/E –Yield –

QuidelOrtho profit margin

Profit margin (net margin) is net income as a percentage of revenue.

QuidelOrtho's profit margin for the twelve months ending Sep 27, 2026 was -14.2%. For fiscal 2025 it was -41.5%, against -73.7% the year before. The highest annual figure on record is 48.8% in fiscal 2020.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 28, 2025-41.5%+32.3
FY2024Dec 29, 2024-73.7%−73.4
FY2023Dec 31, 2023-0.3%−17.1
FY2022Jan 1, 202316.8%−24.7
FY2021Jan 2, 202241.5%−7.3
FY2020Jan 3, 202148.8%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 27, 2026-8.7%+96.0
Q2 FY2026Jun 28, 2026-14.7%+26.9
Q1 FY2026Mar 29, 2026-14.8%−13.0
Q4 FY2025Dec 28, 2025-18.1%+7.1
Q3 FY2025Sep 28, 2025-104.7%−102.0
Q2 FY2025Jun 29, 2025-41.6%−18.4
Q1 FY2025Mar 30, 2025-1.8%+238.1
Q4 FY2024Dec 29, 2024-25.2%−26.1
Q3 FY2024Sep 29, 2024-2.7%−1.0
Q2 FY2024Jun 30, 2024-23.2%−15.2
Q1 FY2024Mar 31, 2024-239.9%−245.7
Q4 FY2023Dec 31, 20230.9%−2.6
Q3 FY2023Oct 1, 2023-1.7%−4.2
Q2 FY2023Jul 2, 2023-8.0%−11.1
Q1 FY2023Apr 2, 20235.8%−42.1
Q4 FY2022Jan 1, 20233.5%−42.2
Q3 FY2022Oct 2, 20222.4%−39.9
Q2 FY2022Jul 3, 20223.1%−7.7
Q1 FY2022Apr 3, 202247.9%–
Q4 FY2021Jan 2, 202245.7%–
Q3 FY2021Oct 3, 202142.3%–
Q2 FY2021Jul 4, 202110.8%–

More QuidelOrtho figures

See a number that looks wrong?